Role of ichemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver

Hepatology

Volumn 26, Issue 2, 1997, Pages 343-350

  Shimamatsu, Kazuhide ^a,c   Wanless, Ian R ^b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; CHRONIC HEPATITIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIVER ATROPHY; LIVER CIRRHOSIS; LIVER HYPERPLASIA; LIVER ISCHEMIA; NODULAR HYPERPLASIA; PORTAL VEIN OBSTRUCTION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; ATROPHY; HYPERPLASIA; ISCHEMIA; LIVER; PATHOLOGY;

APOPTOSIS; ATROPHY; HUMANS; HYPERPLASIA; ISCHEMIA; LIVER; LIVER CIRRHOSIS;

EID: 0030610364     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260214     Document Type: Article

References (28)

1. Kerr JFR. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 1971; 105:13-20.
2. Wyllie AH. Apoptosis: cell death in tissue regulation. J Pathol 1987; 153:313-316.
3. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. HEPATOLOGY 1995; 21:1725-1741.
4. Horrocks P, Tapp E. Zahn's 'infarcts' of the liver. J Clin Pathol 1966; 19:475-478.
5. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. HEPATOLOGY 1990; 11:787-797.
6. International Working Party of World Congresses of Gastroenterology. Terminology of nodular lesions of the liver. HEPATOLOGY 1995; 22:983-993.
7. Searle C, Harmon BV, Bishop CJ, Kerr JFR. The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol 1987; 2:77-96.
8. Mizuno S, Nimura Y, Suzuki H, Yoshida S. Portal vein branch occlusion induces cell proliferation of cholestatic rat liver. J Surg Res 1996; 60: 249-257.
9. Sasaki H, Matsuno T, Tanaka N, Orita K. Activation of apoptosis during the reperfusion phase after rat liver ischemia. Transplant Proc 1996; 28:1908-1909.
10. Schlossberg H, Zhang Y, Dudus L, Engelhardt JF. Expression of c-fos and c-jun during hepatocellular remodeling following ischemia/reperfusion in mouse liver. HEPATOLOGY 1996; 23:1546-55.
11. Allen J, Winterford C, Axelsen RA, Gobe GC. Effects of hypoxia on morphological and biochemical characteristics of renal epithelial cell and tubule cultures. Renal Failure 1992; 14:453-460.
12. Oo TF, Henchcliffe C, Burke RE. Apoptosis in substantia nigra following developmental hypoxic-ischemic injury. Neuroscience 1995; 69:893-901.
13. Dienes HP, Popper H, Arnold W, Lobeck H. Histologic observations in human hepatitis non-A, non-B. HEPATOLOGY 1982; 2:552-571.
14. Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM. Apoptosis in the human liver during allograft rejection and end-stage liver disease. J Pathol 1995; 176:373-380.
15. Rous P, Larimore LD. Relation of the portal blood to liver maintenance. A demonstration of liver atrophy conditional on compensation. J Exp Med 1920; 31:609-632.
16. Steiner PE, Martinez JB. Effects on the rat liver of bile duct, portal vein and hepatic artery ligations. Am J Pathol 1961; 39:257-289.
17. Schweizer W, Duda P, Tanner S, Balsiger D, Hoflin F, Blumgart LH, Zimmermann A. Experimental atrophy/hypertrophy complex (AHC) of the liver: portal vein, but not bile duct obstruction, is the main driving force for the development of AHC in the rat. J Hepatol 1995; 23:71-78.
18. Kusano S, Okada Y, Endo T, Yokoyama H, Ohmiya H, Atari H. Oriental cholangiohepatitis: correlation between portal vein occlusion and hepatic atrophy. AJR 1992; 158:1011-1014.
19. Alison MR, Ryan CJ, Lee CA, McDermott. Compensatory hyperplasia in the rat liver as a result of cytoplasmic atrophy. Br J Exp Pathol 1986; 67:901-908.
20. Kerr JFR. A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J Pathol Bacteriol 1965; 90:419-435.
21. Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). HEPATOLOGY 1995; 21: 1232-1237.
22. Wanless IR, Bargman J, Oreopoulos D, Vas S. Subcapsular steatonecrosis of the liver in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol 1989; 2:69-74.
23. Cummings MC. Increased p53 mRNA expression in liver and kidney apoptosis. Biochim Biophys Acta 1996; 1315:100-104.
24. Ericsson JLE. Mechanisms of cellular autophagy. In: Dingle JT, Fell HB, eds. Lysosomes in Biology and Pathology. Vol 2. Amsterdam-London: North Holland, 1969:345-394.
25. Holen I, Gordon PB, Stromhaug PE, Seglen PO. Role of cAMP in the regulation of hepatocytic autophagy. Eur J Biochem 1996; 236:163-170.
26. Starzl TE, Porter KA, Putnam CW. Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet 1975; 1:1241-1242.
27. Pfeifer U. Kinetic and subcellular aspects of hypertrophy and atrophy. Internat Rev Exp Pathol 1982; 23:1-45.
28. Hadjis NS, Blumgart LH. Clinical aspects of liver atrophy. J Clin Gastroenterol 1989; 11:3-7.